COMBINED INHIBITION OF PHOSPHODIESTERASE-4 (PDE-4) AND PHOSPHODIESTERASE-3 (PDE-3) AS A THERAPY FOR TH1-MEDIATED AUTOIMMUNE DISEASES

Details for Australian Patent Application No. 2002231192 (hide)

Owner THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALT

Inventors MCFARLAND, Henry, F.; MARTIN, Roland; BIELEKOVA, Bibiana

Pub. Number AU-A-2002231192

PCT Pub. Number WO2002/051502

Priority 60/259,270 22.12.00 US

Filing date 21 December 2001

Wipo publication date 8 July 2002

International Classifications

A61P 037/02 Drugs for immunological or allergic disorders

A61K 031/4015 - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002231192

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231193

2002231191-MONITORING AND CONTROLLING SYSTEM WITH CONNECTROLESS QUICK-CHANGE COMPONENTS